Cargando…
Cross-talk between signalling pathways and the multidrug resistant protein MDR-1
The multidrug resistant protein MDR-1 has been associated with the resistance to a wide range of anti-cancer drugs. Taxol is a substrate for this transporter system and is used in the treatment of a wide range of human malignancies including lung, breast and ovarian cancer. We have generated a serie...
Autores principales: | Ding, S, Chamberlain, M, McLaren, A, Goh, L-b, Duncan, I, Wolf, C R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375166/ https://www.ncbi.nlm.nih.gov/pubmed/11710832 http://dx.doi.org/10.1054/bjoc.2001.2044 |
Ejemplares similares
-
Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium
por: Li, M, et al.
Publicado: (1999) -
Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991) -
MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001) -
Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015) -
The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)